A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults
Clinical trial NCT03527173 · COMPLETED
Trial details
- NCT number
- NCT03527173
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-29
- Primary completion
- 2019-05-08
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.